纵横研报
Ticker Detail

002294.SHE

¥38.65+6.39% 信立泰 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
所属产业链专题
Shenzhen Salubris Pharmaceuticals Co Ltd
医疗健康 · 专科与仿制药

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China. The company is involved in the production and supply of pharmaceutical products in the fields of chronic diseases, including cardiovascular and cerebrovascular diseases, diabetes, oncology, osteoporosis, anti-infective diseases, and chronic kidney diseases. It also engages in the research and development, production, and sale of high-end interventional medical devices, such as cardiovascular and cerebrovascular, peripheral vascular, structural heart disease, electrophysiology, and cardiac rhythm management. The company was incorporated in 1998 and is headquartered in Shenzhen, China. Shenzhen Salubris Pharmaceuticals Co., Ltd. operates as a subsidiary of Salubris Pharmaceuticals Co., Ltd.

MARKET 市值 41.39B CNY PE 61.9x Fwd 48.8x 52W ¥29.25 – ¥69.87 EODHD · Q 2025-09-30 · 同步 2026-07-12
QUALITY PEG 1.17 营收 YoY 15.7% ROE 7.4% 营业利润率 20.1% 净利润率 15.0%
ANALYST 股息率 1.56%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制